New York S07668 prohibits the sale of xylazine above 50 grams to individuals under 21 without proof of intended institutional, veterinary, or.

New York S07668 amends the general business law to prohibit businesses from knowingly selling, offering for sale, or delivering xylazine in quantities of 50 grams or more to individuals under the age of 21 without proof of its intended use for institutional, veterinary, or scientific purposes. The act imposes a civil penalty of up to $3,000 for a first violation and $6,500 for subsequent violations, recoverable by the attorney general. All funds collected from these penalties will be deposited into the New York state drug treatment and public education fund.

New York S07668 prohibits the sale of xylazine above 50 grams to individuals under 21 without proof of intended institutional, veterinary, or.

New York S07668 amends the general business law to prohibit businesses from knowingly selling, offering for sale, or delivering xylazine in quantities of 50 grams or more to individuals under the age of 21 without proof of its intended use for institutional, veterinary, or scientific purposes. The act imposes a civil penalty of up to $3,000 for a first violation and $6,500 for subsequent violations, recoverable by the attorney general. All funds collected from these penalties will be deposited into the New York state drug treatment and public education fund.